What is the CAGR Values of Blockchain Technology in Healthcare Market?

Blockchain, which is a shared immutable ledger for tracking assets and recording transactions, is being increasingly used by healthcare organizations to facilitate the process of data recording and asset tracking. Anything of value can be transmitted and tracked on a blockchain network, at low cost and reduced risk. In recent years, the blockchain technology has become an ideal data storing technology for this sector as it offers immediate, shared, and entirely transparent information collected in an immutable ledger that can be accessed only by authorized members.

Thus, due to the exceptional data security offered by this new age record-keeping technology, the blockchain in healthcare market is expected to advance at 67.1% CAGR during 2018–2023. The market was valued at $44.6 million in 2017 and it is projected to reach $890.5 million by 2023. This technology stores data in blocks that are chained together. It links the data in chronological order so that once a new block is filled with the data, it is chained to the preceding block.

The surging use of blockchain technology in the healthcare sector can be also be attributed to the increasing prevalence of data thefts and breaches in this industry. Frequent cases of cyberattacks have encouraged several governments to enact stringent regulations to protect consumer information. For instance, the European Union (EU) implemented the General Data Protection Regulation (GDPR) in March 2018, to protect the personal data of the people residing in the EU member countries.

At present, the blockchain technology is being widely used in the healthcare sector for clinical data exchange and interoperability because of its potential to transform the process of clinical information storage and sharing among healthcare partners and patients. Additionally, the technology is also used by healthcare facilities for claims adjudication and billing management, drug discovery and clinical trials, and drug supply chain management. Moreover, the adoption of blockchain networks also reduces the incidence of abuse of prescribed drugs. 

The widening application base of blockchain technology in pharmaceutical companies and healthcare facilities is encouraging Coral Health Research & Discovery Inc., Blockverify, Patientory Inc., International Business Machines (IBM) Corporation, Doc.ai Inc., iSolve LLC, IRYO.NETWORK, Hashed Health, Proof.Works, PokitDok Inc., DeepMind Technologies Limited, Guardtime AS, Blockpharma, and Microsoft Corporation to engage in partnerships and collaborations so that they can offer their products to a greater number of customers. For example, in January 2018, Guardtime AS signed a deal with NMC Health, a United Arab Emirates (UAE) based private sector healthcare provider, to introduce the technology to the nation. 

According to P&S Intelligence, Europe will dominate the blockchain in healthcare market in the coming years, due to the surging number of blockchain initiatives being launched by private and public companies in the region. For instance, the European Platform on Changing Healthcare (EPOCH) was established to examine and amplify the use of advanced technologies in the European pharmaceutical industry. Whereas, Asia-Pacific (APAC) is expected to progress at the highest rate in the foreseeable years, owing to the escalating use of blockchain in data supply management and data exchange and interoperability in the region. 

Thus, the rising prevalence of data thefts and breaches in the healthcare industry will augment the use of blockchain solutions in this sector in the forthcoming years. 

Comments

Post a Comment

Popular posts from this blog

Huge Growth Expected in Dermacosmetics Market in Future

Image
 The cosmetic industry, while mostly misunderstood as dealing with just the aesthetic appearance, has been undergoing technological advancements and moved beyond face creams and face powders since a long time now. Other than this, the prevalence of skin diseases is also rising across the globe and it has been shown by the Global Burden of Disease project that skin diseases are the 4th leading cause of nonfatal disease burden globally. Moreover, understanding the impact of skin diseases is important as in some cases skin conditions often represent a more severe systemic illness, such as human immunodeficiency virus and neglected tropical diseases.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/dermacosmetics-market/report-sample Attributed to these reasons, the development of dermacosmetics has been made possible. These products are crucial now in the branch of dermatology as they combine cosmetics and scientific techniques for the management of a
Read more

Increasing Occurrence of Spinal Cord Injuries Powering Sales of Exoskeletons

Image
The growing prevalence of stroke and spinal cord injuries (SCIs) is fueling the surge in the demand for exoskeletons in several healthcare settings such as rehabilitation centers across the world. In the healthcare industry, exoskeletons are used for helping paralyzed patients walk. For example, as per the National Spinal Cord Injury Statistical Center (NSCISC), in the U.S., there are around 54 cases of SCIs per one million people, or nearly 17,730 new SCI cases are reported every year. Furthermore, in the U.S., the average number of people suffering from spinal cord injuries is 291,000, with various individual estimates falling in the range of 249,000–363,000. The surging geriatric population in several countries is also fueling the demand for exoskeletons. As per the World Population Ageing 2019 report published by the UN, the total number of people in the age bracket- 65 years or above across the world was 703 million in 2019. Moreover, the public awareness about exoskeletons and th
Read more

How is Rising Prevalence of Chronic Diseases Driving Biobanking Market?

Image
  Despite all the advancements in the healthcare system, pertaining to therapy, diagnosis, and devices, there a number of chronic ailments which cannot be cured, including cancer, Alzheimer’s disease, Parkinson’s disease, human immunodeficiency virus, and the latest COVID-19, to name a few. Research has been going on indefinitely regarding finding a cure for these and several other diseases in order to reduce their growing prevalence. One of the processes for conducting research on a disease and on its treatment is the collection of biological samples and health information, which is referred to as a biobank.    Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/biobanking-market/report-sample Biobanks basically serve as a library for researchers, and reduce the time and resources required for recruiting new participants for each research study as samples and needed medical information are all available at one place. By collecting samples and recru
Read more